Lower riskDrug recall · FDA · Published September 28, 2017
Leading Pharma recalls 0.5mg lorazepam tablets labeled as 0.5mg but contain 1mg
Leading Pharma recalls 500-count lorazepam tablets labeled 0.5mg but contain 1mg. This labeling error may cause incorrect dosing. Consumers should contact the company for details.
“Leading Pharma recalls 0.5mg lorazepam tablets labeled as 0.5mg but contain 1mg.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41161-leading-pharma-recalls-0-5mg-lorazepam-tablets-labeled-as-0. Based on FDA recall #D-0085-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0085-2018%22&limit=1).
The FDA announced on September 28, 2017, that Leading Pharma, LLC voluntarily recalled Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottles due to a labeling error where the bottle contained 1mg tablets instead of the declared strength.
Manufacturer: Leading Pharma, LLC Fairfield, NJ 07004
NDC: 69315-904-05
Lot #: E00717
Quantity: 2952 bottles
Distribution: Nationwide in the USA
The hazard
The hazard is a labeling error regarding the declared strength. The bottle labeled as containing 0.5 mg tablets actually contained 1mg tablets of lorazepam.
Context
GovInfoNow's records show Leading Pharma, LLC has had two other recalls since August 23, 2022, including a March 20, 2026 recall for Furosemide 80mg due to impurity and an August 23, 2022 recall for Clomipramine capsules with high drug content. Other recent recalls of similar products include Safecor Atomoxetine Capsules 10mg Mislabeled as 25mg (April 30, 2026), Meclizine 12.5mg Tablets Recall: Failed Tablet Specifications (March 16, 2026), and American Health Packaging Buprenorphine Tablets Recall: Label Mix-Up Hazard (August 19, 2026).
How to tell if you have this one
Check for the 500-count bottle labeled as 0.5mg with NDC 69315-904-05 and lot number E00717. The product is sold under the brand name Lorazepam.
Brand
Leading Pharma
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Label
Look for the label that states 0.5mg but contains 1mg of lorazepam.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0085-2018 (September 28, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0085-2018 to see it in context.
Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.